These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 39064934)

  • 1. Primed for Interactions: Investigating the Primed Substrate Channel of the Proteasome for Improved Molecular Engagement.
    Loy CA; Trader DJ
    Molecules; 2024 Jul; 29(14):. PubMed ID: 39064934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 20S proteasome hydrolysis of LLVY substrates to determine preferences for moieties in its primed substrate channel.
    Muli CS; Trader DJ
    Bioorg Med Chem Lett; 2023 Apr; 85():129233. PubMed ID: 36905968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasome substrate receptors and their therapeutic potential.
    Osei-Amponsa V; Walters KJ
    Trends Biochem Sci; 2022 Nov; 47(11):950-964. PubMed ID: 35817651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical approaches to targeted protein degradation through modulation of the ubiquitin-proteasome pathway.
    Collins I; Wang H; Caldwell JJ; Chopra R
    Biochem J; 2017 Mar; 474(7):1127-1147. PubMed ID: 28298557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of the Multiple Activities of 26S Proteasomes.
    Kim HT; Collins GA; Goldberg AL
    Methods Mol Biol; 2018; 1844():289-308. PubMed ID: 30242717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-molecule control of intracellular protein levels through modulation of the ubiquitin proteasome system.
    Buckley DL; Crews CM
    Angew Chem Int Ed Engl; 2014 Feb; 53(9):2312-30. PubMed ID: 24459094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Capture of a Disabled Proteasome Identifies Erg25 as a Substrate for Endoplasmic Reticulum Associated Degradation.
    Buck TM; Zeng X; Cantrell PS; Cattley RT; Hasanbasri Z; Yates ME; Nguyen D; Yates NA; Brodsky JL
    Mol Cell Proteomics; 2020 Nov; 19(11):1896-1909. PubMed ID: 32868373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro analysis of proteasome-associated USP14 activity for substrate degradation and deubiquitylation.
    Muniyappan S; Lee BH
    Methods Enzymol; 2019; 619():249-268. PubMed ID: 30910023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-Keto phenylamides as P1'-extended proteasome inhibitors.
    Voss C; Scholz C; Knorr S; Beck P; Stein ML; Zall A; Kuckelkorn U; Kloetzel PM; Groll M; Hamacher K; Schmidt B
    ChemMedChem; 2014 Nov; 9(11):2557-64. PubMed ID: 25087721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in Proteasome Enhancement by Small Molecules.
    George DE; Tepe JJ
    Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the ubiquitin proteasome system in haematological malignancies.
    Crawford LJ; Irvine AE
    Blood Rev; 2013 Nov; 27(6):297-304. PubMed ID: 24183816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small-Molecule Inhibitors Targeting Proteasome-Associated Deubiquitinases.
    Moon S; Muniyappan S; Lee SB; Lee BH
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteasome in action: substrate degradation by the 26S proteasome.
    Sahu I; Glickman MH
    Biochem Soc Trans; 2021 Apr; 49(2):629-644. PubMed ID: 33729481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and biochemical elements of efficiently degradable proteasome substrates.
    Tomita T
    J Biochem; 2022 Mar; 171(3):261-268. PubMed ID: 34967398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substrate selection by the proteasome through initiation regions.
    Tomita T; Matouschek A
    Protein Sci; 2019 Jul; 28(7):1222-1232. PubMed ID: 31074920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the ubiquitin+proteasome system in solid tumors.
    Driscoll JJ; Woodle ES
    Semin Hematol; 2012 Jul; 49(3):277-83. PubMed ID: 22726552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A High-Content Screening Assay for the Discovery of Novel Proteasome Inhibitors from Formosan Soft Corals.
    Ling XH; Wang SK; Huang YH; Huang MJ; Duh CY
    Mar Drugs; 2018 Oct; 16(10):. PubMed ID: 30347865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitin-proteasome system and the role of its inhibitors in cancer therapy.
    Aliabadi F; Sohrabi B; Mostafavi E; Pazoki-Toroudi H; Webster TJ
    Open Biol; 2021 Apr; 11(4):200390. PubMed ID: 33906413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate-specific effects of natural genetic variation on proteasome activity.
    Collins MA; Avery R; Albert FW
    PLoS Genet; 2023 May; 19(5):e1010734. PubMed ID: 37126494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deubiquitination Reactions on the Proteasome for Proteasome Versatility.
    Shin JY; Muniyappan S; Tran NN; Park H; Lee SB; Lee BH
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32726943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.